Skip to Main Content

Paper Details

Ethacridine inhibits SARS-CoV-2 by inactivating viral particles.
PLoS Pathog
24
2021
COVID-19, Ethacridine, SARS, SARS-, SARS-CoV, SARS-CoV-2, ethacridine, host cells, human, living cells, primary human nasal epithelial cells, respiratory disease, viral particles
Author NameAffiliation
Jayakar V NayakStanford University
Peter K JacksonStanford University
Raul AndinoUniversity of California san francisco
Xiaokun ShuDepartment of Pharmaceutical Chemistry, University of California san francisco
Xiaokun ShuCardiovascular Research Institute, University of California san francisco
  • 1 - 5

Datasets

Release 1.2